Carisma Therapeutics, Inc.

NasdaqGM:CARM Stock Report

Market Cap: US$16.7m

Carisma Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CARM?
Owner TypeNumber of SharesOwnership Percentage
Private Companies267,8640.642%
Public Companies2,749,8556.59%
VC/PE Firms3,398,2488.14%
Individual Insiders5,111,60812.2%
Institutions8,012,81019.2%
General Public22,209,72453.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.5%.

Top Shareholders

Top 25 shareholders own 46.6% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.14%
Odlander, Fredrikson & Co. AB
3,398,248US$1.4m0%1.35%
6.59%
AbbVie Inc.
2,749,855US$1.1m0%no data
5.5%
Regina Hodits
2,297,546US$916.7k0%no data
5.31%
Chidozie Ugwumba
2,215,877US$884.1k0%no data
4.95%
Longview Innovation Corp.
2,067,924US$825.1k0%no data
3.47%
The Vanguard Group, Inc.
1,448,247US$577.9k0%no data
3%
University of Pennsylvania, Endowment Arm
1,252,107US$499.6k0%0.81%
1.34%
TPG Capital, L.P.
561,442US$224.0k-33.3%no data
1.32%
Barclays PLC Private Banking & Investment Banking Investment
549,305US$219.2k3,660,000%no data
1.16%
Michael Klichinsky
484,347US$193.3k0%no data
0.98%
BlackRock, Inc.
408,564US$163.0k-42.5%no data
0.9%
IP Group Plc
377,444US$150.6k0%0.11%
0.77%
JEC II Associates LLC
319,991US$127.7k0%4.72%
0.64%
Ipg Usa Sco Lp
267,864US$106.9k0%no data
0.62%
Geode Capital Management, LLC
259,184US$103.4k-8.55%no data
0.5%
Renaissance Technologies LLC
206,757US$82.5k48.4%no data
0.34%
Millennium Management LLC
142,522US$56.9k-11%no data
0.24%
Michael Torok
101,250US$40.4k0%no data
0.2%
State Street Global Advisors, Inc.
85,106US$34.0k0%no data
0.18%
Northern Trust Global Investments
75,451US$30.1k-66.4%no data
0.15%
Bridgeway Capital Management, LLC
60,876US$24.3k5.09%no data
0.084%
Wexford Capital LP
34,861US$13.9k75.5%no data
0.082%
Two Sigma Investments, LP
34,141US$13.6k0%no data
0.079%
Bg Fund Management Luxembourg S.A.
32,819US$13.1k0%no data
0.06%
Blodgett Wealth Advisors, LLC
25,001US$10.0k-1.96%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 00:53
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Carisma Therapeutics, Inc. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Justin ZelinBTIG
Naureen QuibriaCapital One Securities, Inc.